These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 26679962)
21. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid. Oladapo AO; Barner JC; Rascati KL; Strassels SA Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828 [TBL] [Abstract][Full Text] [Related]
22. Association between consistent omalizumab treatment and asthma control. Lafeuille MH; Gravel J; Zhang J; Gorsh B; Figliomeni M; Lefebvre P J Allergy Clin Immunol Pract; 2013 Jan; 1(1):51-7. PubMed ID: 24229822 [TBL] [Abstract][Full Text] [Related]
23. Inhaled corticosteroid adherence and emergency department utilization among Medicaid-enrolled children with asthma. Rust G; Zhang S; Reynolds J J Asthma; 2013 Sep; 50(7):769-75. PubMed ID: 23734973 [TBL] [Abstract][Full Text] [Related]
24. Extent, trends, and determinants of controller/reliever balance in mild asthma: a 14-year population-based study. Khakban A; FitzGerald JM; Tavakoli H; Lynd L; Ehteshami-Afshar S; Sadatsafavi M Respir Res; 2019 Feb; 20(1):44. PubMed ID: 30819154 [TBL] [Abstract][Full Text] [Related]
25. A Longitudinal Examination of the Asthma Medication Ratio in Children with Medicaid. Andrews AL; Brinton DL; Simpson KN; Simpson AN J Asthma; 2020 Oct; 57(10):1083-1091. PubMed ID: 31313611 [No Abstract] [Full Text] [Related]
26. Ratio of controller to total asthma medications: determinants of the measure. Broder MS; Gutierrez B; Chang E; Meddis D; Schatz M Am J Manag Care; 2010 Mar; 16(3):170-8. PubMed ID: 20225912 [TBL] [Abstract][Full Text] [Related]
27. Outcomes associated with initiation of different controller therapies in a Medicaid asthmatic population: a retrospective data analysis. Balkrishnan R; Nelsen LM; Kulkarni AS; Pleasants RA; Whitmire JT; Schechter MS J Asthma; 2005 Feb; 42(1):35-40. PubMed ID: 15801326 [TBL] [Abstract][Full Text] [Related]
28. A retrospective observational study comparing rescue medication use in children on combined versus separate long-acting beta-agonists and corticosteroids. Elkout H; McLay JS; Simpson CR; Helms PJ Arch Dis Child; 2010 Oct; 95(10):817-21. PubMed ID: 20656730 [TBL] [Abstract][Full Text] [Related]
29. Preventive therapy for asthmatic children under Florida Medicaid: changes during the 1990s. David C J Asthma; 2004 Sep; 41(6):655-61. PubMed ID: 15584315 [TBL] [Abstract][Full Text] [Related]
30. Adherence to prescribed treatment for asthma: evidence from pharmacy benefits data. Jones C; Santanello NC; Boccuzzi SJ; Wogen J; Strub P; Nelsen LM J Asthma; 2003 Feb; 40(1):93-101. PubMed ID: 12699217 [TBL] [Abstract][Full Text] [Related]
31. Oral Corticosteroid Prescribing for Children With Asthma in a Medicaid Managed Care Program. Farber HJ; Silveira EA; Vicere DR; Kothari VD; Giardino AP Pediatrics; 2017 May; 139(5):. PubMed ID: 28557753 [TBL] [Abstract][Full Text] [Related]
32. SABAs as Reliever Medications in Asthma Management: Evidence-Based Science. Amirav I; Garcia G; Le BK; Barria P; Levy G; Aggarwal B; Fahrbach K; Martin A; Phansalkar A; Sriprasart T Adv Ther; 2023 Jul; 40(7):2927-2943. PubMed ID: 37280414 [TBL] [Abstract][Full Text] [Related]
33. The association between hydroxyurea adherence and opioid utilization among Texas Medicaid enrollees with sickle cell disease. Kang HA; Barner JC J Manag Care Spec Pharm; 2020 Nov; 26(11):1412-1422. PubMed ID: 33119448 [No Abstract] [Full Text] [Related]
34. Evaluation of asthma medication adherence rates and strategies to improve adherence in the underserved population at a Federally Qualified Health Center. Bidwal M; Lor K; Yu J; Ip E Res Social Adm Pharm; 2017; 13(4):759-766. PubMed ID: 27595427 [TBL] [Abstract][Full Text] [Related]
35. A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan. Abughosh SM; Wang X; Serna O; Henges C; Masilamani S; Essien EJ; Chung N; Fleming M J Manag Care Spec Pharm; 2016 Jan; 22(1):63-73. PubMed ID: 27015053 [TBL] [Abstract][Full Text] [Related]
36. Underuse of controller medications among Medicaid-insured children with asthma. Finkelstein JA; Lozano P; Farber HJ; Miroshnik I; Lieu TA Arch Pediatr Adolesc Med; 2002 Jun; 156(6):562-7. PubMed ID: 12038888 [TBL] [Abstract][Full Text] [Related]
37. Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America. Quint JK; Arnetorp S; Kocks JWH; Kupczyk M; Nuevo J; Plaza V; Cabrera C; Raherison-Semjen C; Walker B; Penz E; Gilbert I; Lugogo NL; van der Valk RJP; J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2297-2309.e10. PubMed ID: 35364341 [TBL] [Abstract][Full Text] [Related]
38. Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States. Averell CM; Laliberté F; Germain G; Duh MS; Rousculp MD; MacKnight SD; Slade DJ Ther Adv Respir Dis; 2022; 16():17534666221116997. PubMed ID: 36036456 [TBL] [Abstract][Full Text] [Related]
39. Anti-inflammatory medication adherence, healthcare utilization and expenditures among Medicaid and children's health insurance program enrollees with asthma. Herndon JB; Mattke S; Evans Cuellar A; Hong SY; Shenkman EA Pharmacoeconomics; 2012 May; 30(5):397-412. PubMed ID: 22268444 [TBL] [Abstract][Full Text] [Related]
40. Short-acting β-agonist use and its ability to predict future asthma-related outcomes. Stanford RH; Shah MB; D'Souza AO; Dhamane AD; Schatz M Ann Allergy Asthma Immunol; 2012 Dec; 109(6):403-7. PubMed ID: 23176877 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]